Bnp Paribas Arbitrage, Snc »

Outlook Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-03-31 $54k 4.5k 11.94

More positions owned by Bnp Paribas Arbitrage, Snc

Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
NVIDIA Corp Equity (NVDA)
Meta Platforms Equity (META)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)
Industrial Select Sector SPDR Fund Fund (XLI)
Exxon Mobil Corp Equity (XOM)
iShares Russell 2000 ETF Fund (IWM)
Visa Equity (V)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOG)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Outlook Therapeutics

Tang Capital Management
Dr. Jeffrey R. Jay, M.D.
Armistice Capital
Sphera Funds Management
BlackRock
Velan Capital Investment Management
Caligan Partners
Vanguard Group
Schonfeld Strategic Advisors
Geode Capital Management
Northern Trust
Bank of America Corporation
Walleye Trading Advisors
Hrt Financial
Millennium Management

View all funds holding Outlook Therapeutics